过去一年中添加的文章,按日期排序

Evaluation of DihydroartemisininPiperaquine Efficacy and Molecular Markers in Uncomplicated Falciparum Patients: A Study across Binh Phuoc and Dak Nong …

THT Tran, BTT Hien, NTL Dung, NT Huong, TT Binh… - Medicina, 2024 - mdpi.com
18 天前 - Dihydroartemisinin (DHA)–Piperaquine (PPQ) regimen in treating uncomplicated
falciparum malaria and to conduct molecular surveillance of antimalarial drug resistance in …

Investigating the mechanism of action of a highly potent haloalkoxyacridone against Plasmodium falciparum

J Charlton - 2024 - scholar.dominican.edu
53 天前 - … We demonstrate that T111-resistant lines did not confer cross resistance to
standard antimalarials such as, chloroquine, lumefantrine, piperaquine and dihydroartemisinin. …

Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in …

AM Dorkenoo, M Warsame, E Ataba, M Hemou… - Malaria Journal, 2024 - Springer
97 天前 - treatment of uncomplicated Plasmodium falciparum infections is the cornerstone
of malaria … -based combinations for the treatment of uncomplicated falciparum malaria [2]: …

Dihydroartemisininpiperaquine treatment failure of uncomplicated Plasmodium falciparum malaria infection in a traveller

O Delandre, NS Cassir, N Taudon… - Journal of Travel …, 2024 - academic.oup.com
122 天前 - … firstline therapy and the efficacy of dihydroartemisininpiperaquine (DHA-PPQ) at
42-… We report a late DHA-PPQ treatment failure of uncomplicated Plasmodium falciparum (Pf) …

Therapeutic response to four artemisinin-based combination therapies in Angola, 2021

PR Dimbu, S Labuda, CM Ferreira… - Antimicrobial Agents …, 2024 - Am Soc Microbiol
130 天前 - … –amodiaquine, and dihydroartemisininpiperaquine for the treatment of uncomplicated
Plasmodium falciparum malaria in three provinces in Angola, 2017. Malar J 17:144. …

Ex vivo drug susceptibility and resistance mediating genetic polymorphisms of Plasmodium falciparum in Bobo-Dioulasso, Burkina Faso

AF Somé, MD Conrad, Z Kabré, A Fofana… - Antimicrobial Agents …, 2024 - Am Soc Microbiol
132 天前 - dihydroartemisininpiperaquine (DP) and artesunate–pyronaridine, have been
approved to treat uncomplicated malaria (2… (5), seasonal malaria chemoprevention (SMC) with …

… Resistance: Insights from Plasmodium Falciparum Plasmepsine 2 Gene (Pfpm2) Copy Number Analysis in Côte D'Ivoire Before Dihydroartemisinin-Piperaquine …

BA Ako, AKB Kouman, SB Assi, Y Ouattara… - Available at SSRN … - papers.ssrn.com
166 天前 - … safe ACT for treating uncomplicated P. falciparum malaria in this region (Tindana
et al., 2022). 120 … participants of all ages and genders who presented with uncomplicated P. …

PA-728 Exploring the disposition of select artemisinin combination therapies in the treatment of malaria and malaria parasite kinetics in children with sickle cell …

GA Otieno, BR Ogutu - 2023 - gh.bmj.com
221 天前 - … -RDT) and treatment of those found infected using dihydroartemisinin piperaquine
(DP), in addition to standard intermittent preventive treatment in pregnancy with sulfadoxine-…

… review of the efficacy of artemisinin-based combination therapy (ACT) in people living with HIV (PLHIV) diagnosed with uncomplicated Plasmodium falciparum malaria …

…, E Harriss, V Carrara, K Barnes, P Dahal… - BMJ Global …, 2023 - gh.bmj.com
221 天前 - … aims to assess the treatment outcomes … malaria treatment outcomes or antimalarial
drug exposure (area under the curve, concentration) in PLHIV treated for falciparum malaria

Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or …

…, P Olupot-Olupot, W Were, C Namayanja, P Onyas… - BMC medicine, 2023 - Springer
263 天前 - … acute uncomplicated P. falciparum and day (D) 0 Hbs ≥ 6 g/dL who were treated
with … artemether lumefantrine (AL) or dihydroartemisinin piperaquine (DHAPP). Genotyping …